These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 10425322

  • 1. Cross-linked amylose tablets containing alpha-amylase: an enzymatically-controlled drug release system.
    Dumoulin Y, Cartilier LH, Mateescu MA.
    J Control Release; 1999 Aug 05; 60(2-3):161-7. PubMed ID: 10425322
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile.
    Nabais T, Zaraa S, Leclair G.
    Drug Dev Ind Pharm; 2016 Nov 05; 42(11):1887-93. PubMed ID: 27109692
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The preparation and kinetic study on enzymatically-controlled drug release of isotretinoin/amylose inclusion complex].
    Wang QF, Li SM, Zhang TH, Yu J, Hu ZS, Li Y.
    Yao Xue Xue Bao; 2012 Sep 05; 47(9):1227-30. PubMed ID: 23227555
    [Abstract] [Full Text] [Related]

  • 11. Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study.
    Mulhbacher J, Ispas-Szabo P, Mateescu MA.
    Int J Pharm; 2004 Jul 08; 278(2):231-8. PubMed ID: 15196628
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemically-modified polysaccharides for enzymatically-controlled oral drug delivery.
    Kost J, Shefer S.
    Biomaterials; 1990 Nov 08; 11(9):695-8. PubMed ID: 2090305
    [Abstract] [Full Text] [Related]

  • 17. Imaging of high-amylose starch tablets. 3. Initial diffusion and temperature effects.
    Thérien-Aubin H, Baille WE, Zhu XX, Marchessault RH.
    Biomacromolecules; 2005 Nov 08; 6(6):3367-72. PubMed ID: 16283767
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets.
    Onofre FO, Wang YJ.
    Int J Pharm; 2010 Jan 29; 385(1-2):104-12. PubMed ID: 19879935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.